Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Theriva Biologics Receives FDA Fast Track Designation For VCN-01 In Combination With Gemcitabine And Nab-Paclitaxel To Improve Survival In Metastatic Pancreatic Adenocarcinoma

Author: Benzinga Newsdesk | May 23, 2024 08:20am

Posted In: TOVX